Obalon Therapeutics, Inc. OBLN
52-week range unavailable
- Open
- 3.25
- Prev close
- 3.05
- Mkt cap
- 30.57M
- Vol
- 26.47M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.95
- High
- 4.80
- Forward P/E
- -11.30
- Beta
- -1.24
- Short ratio
- 0.08
- Inst. own
- 31.70%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jul 29, 2021
- 50-d avg
- 9.14
- 200-d avg
- 9.08
- 1y target
- 6.15
MAX chart
Chart tools
Chart is warming up
The all-time price history for OBLN has not been loaded yet. Try again in a moment.
Altman Z-Score
-14.83 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E 0.0×
P/S 0.0×
P/B 0.0×
P/FCF 0.0×
EV/EBITDA 0.5×
EV/Sales -15.5×
FCF Yield 0.0%
Gross Margin 68.4%
Operating Margin -3237.8%
Net Margin -3277.2%
ROE -278.5%
ROIC -272.9%
ROA -161.3%
Revenue -96.0%
Operating Income -55.2%
EPS (diluted) 100.0%
Free Cash Flow 100.0%
Current Ratio 2.0×
Quick Ratio 2.0×
Debt / Equity 0.0×
Net Debt / EBITDA 0.5×
Interest Coverage 70.6×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31